Bile acids for metabolic dysfunction-associated steatotic liver disease in adults.

ABSTRACT:

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).

SUBMITTER: Ashmawy RE 

PROVIDER: S-EPMC12403225 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature